These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26979759)

  • 1. The role of triacylglycerol in cardiac energy provision.
    Evans RD; Hauton D
    Biochim Biophys Acta; 2016 Oct; 1861(10):1481-91. PubMed ID: 26979759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial triacylglycerol metabolism.
    Kienesberger PC; Pulinilkunnil T; Nagendran J; Dyck JR
    J Mol Cell Cardiol; 2013 Feb; 55():101-10. PubMed ID: 22789525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat in the heart: The enzymatic machinery regulating cardiac triacylglycerol metabolism.
    Heier C; Haemmerle G
    Biochim Biophys Acta; 2016 Oct; 1861(10):1500-12. PubMed ID: 26924251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilisation of triacylglycerol and non-esterified fatty acid by the working rat heart: myocardial lipid substrate preference.
    Hauton D; Bennett MJ; Evans RD
    Biochim Biophys Acta; 2001 Sep; 1533(2):99-109. PubMed ID: 11566447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid metabolism and signaling in cardiac lipotoxicity.
    D'Souza K; Nzirorera C; Kienesberger PC
    Biochim Biophys Acta; 2016 Oct; 1861(10):1513-24. PubMed ID: 26924249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates.
    Niu YG; Hauton D; Evans RD
    J Physiol; 2004 Jul; 558(Pt 1):225-37. PubMed ID: 15121801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
    Niu YG; Evans RD
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
    Fukushima A; Lopaschuk GD
    Biochim Biophys Acta; 2016 Oct; 1861(10):1525-34. PubMed ID: 26996746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triacylglycerol turnover in the failing heart.
    Carley AN; Lewandowski ED
    Biochim Biophys Acta; 2016 Oct; 1861(10):1492-9. PubMed ID: 26993578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of CD36 in the regulation of myocardial lipid metabolism.
    Kim TT; Dyck JR
    Biochim Biophys Acta; 2016 Oct; 1861(10):1450-60. PubMed ID: 26995462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover.
    O'Donnell JM; Fields AD; Sorokina N; Lewandowski ED
    J Mol Cell Cardiol; 2008 Feb; 44(2):315-22. PubMed ID: 18155232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfused heart studies to investigate lipid metabolism.
    Evans RD; Bennett MJ; Hauton D
    Biochem Soc Trans; 2000 Feb; 28(2):113-20. PubMed ID: 10816111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Protective Role for Triacylglycerols during Apoptosis.
    Li N; Sancak Y; Frasor J; Atilla-Gokcumen GE
    Biochemistry; 2018 Jan; 57(1):72-80. PubMed ID: 29188717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins.
    Dolinsky VW; Cole LK; Sparagna GC; Hatch GM
    Biochim Biophys Acta; 2016 Oct; 1861(10):1544-54. PubMed ID: 26972373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid partitioning during cardiac stress.
    Kolwicz SC
    Biochim Biophys Acta; 2016 Oct; 1861(10):1472-80. PubMed ID: 27040509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modifications in myocardial energy metabolism in diabetic patients]].
    Grynberg A
    Diabetes Metab; 2001 Nov; 27(5 Pt 2):S12-9. PubMed ID: 11910980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of myocardial triacylglycerol synthesis and metabolism.
    Lewin TM; Coleman RA
    Biochim Biophys Acta; 2003 Nov; 1634(3):63-75. PubMed ID: 14643794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fuel availability and fate in cardiac metabolism: A tale of two substrates.
    Pascual F; Coleman RA
    Biochim Biophys Acta; 2016 Oct; 1861(10):1425-33. PubMed ID: 26993579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic engineering of sugarcane to accumulate energy-dense triacylglycerols in vegetative biomass.
    Zale J; Jung JH; Kim JY; Pathak B; Karan R; Liu H; Chen X; Wu H; Candreva J; Zhai Z; Shanklin J; Altpeter F
    Plant Biotechnol J; 2016 Feb; 14(2):661-9. PubMed ID: 26058948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipotoxicity in obesity and diabetes-related cardiac dysfunction.
    Zlobine I; Gopal K; Ussher JR
    Biochim Biophys Acta; 2016 Oct; 1861(10):1555-68. PubMed ID: 26899197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.